Suppr超能文献

[胎儿/新生儿同种免疫性血小板减少症:未解决的问题]

[Fetal/neonatal allo-immune thrombocytopenias: the unsolved questions].

作者信息

Kaplan C

机构信息

Laboratoire d'immunologie plaquettaire, INTS, 6, Paris, France.

出版信息

Transfus Clin Biol. 2005 Jun;12(2):131-4. doi: 10.1016/j.tracli.2005.04.012.

Abstract

The allo-immune thrombocytopenias are the major cause of severe thrombocytopenia in the fetus and the neonate. The frequency of this affection has been evaluated to be 1 out of 800 to 1000 live births. The deleterious consequences of severe thrombocytopenia are intracranial hemorrhages leading to death or neurological sequelae. Progress in platelet immunology and antenatal medicine has allowed a better diagnosis of this affection and development of the antenatal management of high-risk pregnancies. Nevertheless there are unsolved questions, particularly concerning the mechanism of the maternal immunization, the laboratory difficulties for the identification of the alloantibodies, the absence of antenatal management standardization.

摘要

同种免疫性血小板减少症是胎儿和新生儿严重血小板减少的主要原因。据评估,这种疾病在每800至1000例活产中的发病率为1例。严重血小板减少症的有害后果是颅内出血,可导致死亡或神经后遗症。血小板免疫学和产前医学的进展使得对这种疾病有了更好的诊断,并发展了高危妊娠的产前管理。然而,仍有一些未解决的问题,特别是关于母体免疫的机制、同种抗体鉴定的实验室困难以及产前管理缺乏标准化。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验